Journal of Pharmaceutical Analysis · 2023 · 20 citations · 26 references
MedicineOncologyPharmacologyCancer PharmacologyCell SignalingMolecular OncologyCancer BiomarkersCancer Cell SignalingCancer ProteomicsPlant Immune SignalingAnticancer ActivityAnticancer Natural ProductsPd-1 SignalingProgrammed Cell Death Protein 1 (Pd-1) PathwayProgrammed Death-ligand 1 SignalingProtein TargetsProteomic Data AnalysisSecondary Metabolites
Lung cancer ranks the top of malignancies that cause cancer-related deaths worldwide. The leaves of Morus alba L are traditional Chinese medicine widely applied in respiratory diseases. Our previous work has demonstrated the anti-lung cancer effect of secondary metabolites of mulberry leaf. But their mechanism of action has still not fully elucidated. We synthesized Moracin N (MAN) probe conjugated with alkyne to label lung cancer cells and identified protein targets by chemical proteomic analysis. MAN and its probe exerted similar growth-inhibitory effect on human lung cancer cells. Chemical proteomic results showed that MAN targeted the programmed death ligand 1 (PD-L1) checkpoint pathway and T cell receptor (TCR) signaling pathway, indicating its immune-regulatory function. Cell-free surface plasmon resonance (SPR) results showed the direct interaction of MAN with PD-L1 protein. Molecular docking analysis demonstrated that MAN bound to E158 residue of PD-L1 protein. MAN downregulated the expression levels of PD-L1 in a time- and dose-dependent manner and disrupted the PD-L1/programmed death 1 (PD-1) binding, including other secondary metabolites of mulberry leaves Guangsangon E (GSE) and Chalcomoracin (CMR). Human peripheral blood mononuclear cells (PBMCs) co-cultured with MAN-treated A549 cells, resulting in the increase of cluster of differentiation (CD)8+ Granzyme B (GZMB)+ T cells and the decrease of CD8+PD-1+ T cells. It suggested that MAN exerts anti-cancer effect through blocking the PD-L1/PD-1 signaling. In vivo, MAN combined with anti-PD-1 antibody significantly inhibited lung cancer development and metastasis, indicating their synergistic effect. Taken together, secondary metabolites of mulberry leaves target the PD-L1/PD-1 signaling, enhance T cell-mediated immunity and inhibit the tumorigenesis of lung cancer. Their modulatory effect on tumor microenvironment makes them able to enhance the therapeutic efficacy of immune checkpoint inhibitors in lung cancer.
26
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
Chia‐Wei Li, Seung-Oe Lim, Weiya Xia et al. · Nature Communications · 2016 · 1.1K citations · Full text
Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillance
Jinfang Zhang, Xia Bu, Haizhen Wang et al. · Nature · 2017 · 1K citations · Full text
Medicine, Cancer Biology, Oncology +17
Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1
Jong‐Ho Cha, Wenhao Yang, Weiya Xia et al. · Molecular Cell · 2018 · 758 citations
Medicine, Immunology, Oncology +14
Identification of CMTM6 and CMTM4 as PD-L1 protein regulators
Riccardo Mezzadra, Chong Sun, Lucas T. Jae et al. · Nature · 2017 · 703 citations · Full text
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers
Justina X. Caushi, Jiajia Zhang, Zhicheng Ji et al. · Nature · 2021 · 547 citations · Full text
Life Sciences, Immunology, Oncology +17